MUSCLE STIMULATION DEVICES MARKET ANALYSIS

Muscle Stimulation Devices MarketSize and Trends

The global muscle stimulation devices market is estimated to be valued at US$  756.7 million in 2023 and is expected to exhibit a CAGR of 3.8% during the forecast period (2023-2030).

To enable a platform that is rapid, efficient sample processing and the market is being driven primarily by the rising prevalence of musculoskeletal disorders and the increasing trend of physical fitness worldwide. Muscle stimulators are medical devices that use electrical impulses to contract muscles, helping to reduce pain, increase muscle strength, and promote muscle relaxation.  Global muscle stimulation devices market over the forecast period. For instance, in April 2021, Therabody, Inc. is wellness technology company, announced that it has acquired the PowerDot. Smart Muscle Stimulator. It is use for neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS) send electronic pulses to stimulate motor nerves to create muscle contraction and stimulate sensory nerves to temporarily relieve pain.  

Figure 1. Global Muscle Stimulation Devices Market Share (%), by Product Type, 2023

Global muscle stimulation devices market – Driver

Increasing incidence of head and spinal cord injuries

Increasing incidence of head and spinal cord injuries is expected to boost growth of the global muscle stimulation devices market over the forecast period. For instance, According to National Library of Medicine in May 2022, Globally, between 250,000 and 500,000 patients, each year suffer a spinal cord injury. Most of these cases are due to preventable causes such as violence and motor vehicle accidents. In the U.S., there are approximately 17,000 new cases of spinal cord injuries each year, and roughly 282,000 persons are estimated to be living with spinal cord injuries.

Global Muscle Stimulation Devices Market:

Rising demand of stimulation device, increasing need to treat paralytic patients and surging demand of combination therapy can drive the growth of market

Rising demand of stimulation device, increasing need to treat paralytic patients and surging demand of combination therapy, the muscle stimulation devices market is expected to experience considerable expansion in the North American region. For instance, on April 10, 2023, Reach Neuro, Inc. is Medical equipment manufacturer in Pittsburgh, Pennsylvania. received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its Avantis system directly restores a patient’s ability to control movement and upper body paralysis treatment for stroke patients.